Cognition Therapeutics, Inc(CGTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CGTX Cognition Therapeutics, Inc

交易中 08-16 14:27:59 EDT

0.7126

+0.0706

+11.00%

最高0.7345	最低0.6500	成交量63.72万
今开0.6500	昨收0.6420	日振幅13.16%
总市值2,860万	流通市值2,418万	总股本4,013万
成交额44.80万	换手率1.88%	流通股本3,393万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CGTX","market":"US","secType":"STK","nameCN":"Cognition Therapeutics, Inc","latestPrice":0.7126,"timestamp":1723832837154,"preClose":0.642,"halted":0,"volume":637176,"delay":0,"floatShares":33926338,"shares":40132961,"eps":-0.923027,"marketStatus":"交易中","marketStatusCode":2,"change":0.0706,"latestTime":"08-16 14:27:59 EDT","open":0.65,"high":0.7345,"low":0.65,"amount":448033.23540959996,"amplitude":0.13162,"askPrice":0.7118,"askSize":5,"bidPrice":0.71,"bidSize":40,"shortable":3,"etf":0,"ttmEps":-0.923027,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1723838400000},"adr":0,"listingDate":1633665600000,"adjPreClose":0.642,"preHourTrading":{"tag":"盘前","latestPrice":0.6596,"preClose":0.642,"latestTime":"09:21 EDT","volume":15250,"amount":9964.80811,"timestamp":1723814490960},"postHourTrading":{"tag":"盘后","latestPrice":0.644,"preClose":0.642,"latestTime":"19:36 EDT","volume":12422,"amount":7915.74887,"timestamp":1723764966502},"volumeRatio":1.423838},"requestUrl":"/m/hq/s/CGTX","defaultTab":"news","newsList":[{"id":"2459172458","title":"Cognition Therapeutics, Inc.盘中异动 股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459172458","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459172458?lang=zh_cn&edition=full","pubTime":"2024-08-14 21:31","pubTimestamp":1723642319,"startTime":"0","endTime":"0","summary":"北京时间2024年08月14日21时31分，Cognition Therapeutics, Inc.股票出现波动，股价大幅上涨5.08%。Cognition Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.28%。Cognition Therapeutics, Inc.公司简介：Cognition Therapeutics Inc 是一家临床阶段的生物制药公司，致力于发现和开发针对与年龄相关的退行性疾病和中枢神经系统和视网膜疾病的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408142131599598854c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408142131599598854c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CGTX","BK4139","LENZ"],"gpt_icon":0},{"id":"2458862981","title":"Cognition Therapeutics, Inc.盘中异动 早盘股价大涨5.04%报0.575美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458862981","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458862981?lang=zh_cn&edition=full","pubTime":"2024-08-12 22:09","pubTimestamp":1723471742,"startTime":"0","endTime":"0","summary":"北京时间2024年08月12日22时09分，Cognition Therapeutics, Inc.股票出现异动，股价大幅上涨5.04%。截至发稿，该股报0.575美元/股，成交量13.6397万股，换手率0.34%，振幅4.02%。Cognition Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.78%。Cognition Therapeutics, Inc.公司简介：Cognition Therapeutics Inc 是一家临床阶段的生物制药公司，致力于发现和开发针对与年龄相关的退行性疾病和中枢神经系统和视网膜疾病的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240812220902af9716ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240812220902af9716ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CGTX","BK4007"],"gpt_icon":0},{"id":"2458780548","title":"Cognition Therapeutics, Inc.盘中异动 下午盘大幅跳水5.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458780548","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458780548?lang=zh_cn&edition=full","pubTime":"2024-08-10 02:52","pubTimestamp":1723229551,"startTime":"0","endTime":"0","summary":"北京时间2024年08月10日02时52分，Cognition Therapeutics, Inc.股票出现异动，股价快速下跌5.97%。Cognition Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为2.44%。Cognition Therapeutics, Inc.公司简介：Cognition Therapeutics Inc 是一家临床阶段的生物制药公司，致力于发现和开发针对与年龄相关的退行性疾病和中枢神经系统和视网膜疾病的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240810025231af96d785&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240810025231af96d785&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","CGTX","LENZ"],"gpt_icon":0},{"id":"2457184247","title":"Cognition Therapeutics, Inc.盘中异动 快速下挫5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457184247","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457184247?lang=zh_cn&edition=full","pubTime":"2024-08-07 21:55","pubTimestamp":1723038922,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日21时55分，Cognition Therapeutics, Inc.股票出现异动，股价急速跳水5.52%。Cognition Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.41%。Cognition Therapeutics, Inc.公司简介：Cognition Therapeutics Inc 是一家临床阶段的生物制药公司，致力于发现和开发针对与年龄相关的退行性疾病和中枢神经系统和视网膜疾病的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807215523941ff0eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807215523941ff0eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CGTX","BK4007","BK4139"],"gpt_icon":0},{"id":"2457079021","title":"B. Riley Securities：下调Cognition Therapeutics(CGTX.US)评级，由买入调整至中性评级, 目标价由5.","url":"https://stock-news.laohu8.com/highlight/detail?id=2457079021","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457079021?lang=zh_cn&edition=full","pubTime":"2024-08-07 01:20","pubTimestamp":1722964850,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4007","LENZ","BK4139","CGTX"],"gpt_icon":0},{"id":"2457026998","title":"Cognition Therapeutics Inc   预计每股亏损24美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2457026998","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457026998?lang=zh_cn&edition=full","pubTime":"2024-08-06 22:20","pubTimestamp":1722954015,"startTime":"0","endTime":"0","summary":"   * Cognition Therapeutics Inc    将于8月8日公布截至2024年6月30日的财报，预计该公司的季度营收将保持不变。*    * LSEG 的分析师平均预计 Cognition Therapeutics Inc 每股亏损 24 美分。* 华尔街对 Cognition Therapeutics Inc 的 12 个月目标价中位数为 7.00 美元，高于上一次 0.66 美元的收盘价。8月6日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","CGTX"],"gpt_icon":0},{"id":"2456282899","title":"Cognition Therapeutics, Inc.盘中异动 股价大跌5.07%报0.854美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456282899","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456282899?lang=zh_cn&edition=full","pubTime":"2024-08-02 21:36","pubTimestamp":1722605778,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日21时36分，Cognition Therapeutics, Inc.股票出现异动，股价大幅下挫5.07%。Cognition Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.23%。Cognition Therapeutics, Inc.公司简介：Cognition Therapeutics Inc 是一家临床阶段的生物制药公司，致力于发现和开发针对与年龄相关的退行性疾病和中枢神经系统和视网膜疾病的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080221361896823420&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080221361896823420&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CGTX","BK4007","BK4139"],"gpt_icon":0},{"id":"2455131470","title":"Cognition Therapeutics, Inc.盘中异动 股价大跌7.27%报1.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455131470","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455131470?lang=zh_cn&edition=full","pubTime":"2024-07-31 21:32","pubTimestamp":1722432734,"startTime":"0","endTime":"0","summary":"北京时间2024年07月31日21时32分，Cognition Therapeutics, Inc.股票出现异动，股价大幅下跌7.27%。Cognition Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.73%。Cognition Therapeutics, Inc.公司简介：Cognition Therapeutics Inc 是一家临床阶段的生物制药公司，致力于发现和开发针对与年龄相关的退行性疾病和中枢神经系统和视网膜疾病的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024073121321495718449&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024073121321495718449&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LENZ","CGTX"],"gpt_icon":0},{"id":"2455890055","title":"Cognition Therapeutics公司：H.C. Wainwright 将目标价从10美元下调至7美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2455890055","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455890055?lang=zh_cn&edition=full","pubTime":"2024-07-31 18:15","pubTimestamp":1722420934,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LENZ","BK4007","CGTX","BK4139"],"gpt_icon":0},{"id":"2455930337","title":"Cognition Therapeutics, Inc.股价重挫15.01% 市值跌679.68万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455930337","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455930337?lang=zh_cn&edition=full","pubTime":"2024-07-30 21:31","pubTimestamp":1722346264,"startTime":"0","endTime":"0","summary":"北京时间2024年07月30日21时31分，Cognition Therapeutics, Inc.股票出现异动，股价急速跳水15.01%。Cognition Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.66%。Cognition Therapeutics, Inc.公司简介：Cognition Therapeutics Inc 是一家临床阶段的生物制药公司，致力于发现和开发针对与年龄相关的退行性疾病和中枢神经系统和视网膜疾病的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407302131049efda77d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407302131049efda77d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CGTX","BK4007","BK4139","LENZ"],"gpt_icon":0},{"id":"2455663768","title":"【Cognition Therapeutics(CGTX.US)阿尔茨海默病药物CT1812试验取得积极结果】智通财经APP获悉，7月29日，生物制药公司Cognition Therapeutics(CGTX.","url":"https://stock-news.laohu8.com/highlight/detail?id=2455663768","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455663768?lang=zh_cn&edition=full","pubTime":"2024-07-29 21:39","pubTimestamp":1722260393,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["CGTX","BK4007","PACI.U","LENZ","BK4139"],"gpt_icon":0},{"id":"2455632466","title":"Cognition Therapeutics(CGTX.US)阿尔茨海默病药物CT1812试验取得积极结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2455632466","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455632466?lang=zh_cn&edition=full","pubTime":"2024-07-29 21:39","pubTimestamp":1722260393,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，7月29日，生物制药公司Cognition Therapeutics公布了概念性验证2期“SHINE”研究，结果显示其每日一次的实验性口服药物CT1812对轻至中度阿尔茨海默病患者的认知结果持续改善。具体而言，与安慰剂相比，CT1812治疗在认知测量方面平均改善约40%。试验数据公布后，Cognition Therapeutics股价盘前一度大涨近50%。不过，Cognition Therapeutics随后又表示，CT1812在关注症状严重程度的主要疗效终点上未能在统计学上击败安慰剂——或未能突破公司自己的成功标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1157107.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4007","CGTX","BK4139","LENZ"],"gpt_icon":0},{"id":"2455539176","title":"Cognition Therapeutics Inc：Ct1812治疗显示较安慰剂组有约40％的认知措施平均改善。","url":"https://stock-news.laohu8.com/highlight/detail?id=2455539176","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455539176?lang=zh_cn&edition=full","pubTime":"2024-07-29 19:01","pubTimestamp":1722250879,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["CGTX","LENZ","BK4139","BK4007"],"gpt_icon":0},{"id":"2454328324","title":"Cognition Therapeutics, Inc.盘中异动 股价大涨5.71%报2.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454328324","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454328324?lang=zh_cn&edition=full","pubTime":"2024-07-26 21:41","pubTimestamp":1722001266,"startTime":"0","endTime":"0","summary":"北京时间2024年07月26日21时41分，Cognition Therapeutics, Inc.股票出现异动，股价大幅上涨5.71%。Cognition Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。Cognition Therapeutics, Inc.公司简介：Cognition Therapeutics Inc 是一家临床阶段的生物制药公司，致力于发现和开发针对与年龄相关的退行性疾病和中枢神经系统和视网膜疾病的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726214107af945971&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240726214107af945971&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CGTX","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2451625107","title":"Cognition Therapeutics, Inc.盘中异动 早盘快速拉升5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451625107","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451625107?lang=zh_cn&edition=full","pubTime":"2024-07-15 22:02","pubTimestamp":1721052138,"startTime":"0","endTime":"0","summary":"北京时间2024年07月15日22时02分，Cognition Therapeutics, Inc.股票出现异动，股价快速上涨5.05%。Cognition Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.86%。Cognition Therapeutics, Inc.公司简介：Cognition Therapeutics Inc 是一家临床阶段的生物制药公司，致力于发现和开发针对与年龄相关的退行性疾病和中枢神经系统和视网膜疾病的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715220219aef9c132&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240715220219aef9c132&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CGTX","BK4139","BK4007"],"gpt_icon":0},{"id":"2450711817","title":"Cognition Therapeutics, Inc.盘中异动 临近午盘大幅下跌5.48%报1.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450711817","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450711817?lang=zh_cn&edition=full","pubTime":"2024-07-10 23:55","pubTimestamp":1720626907,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日23时55分，Cognition Therapeutics, Inc.股票出现波动，股价急速下挫5.48%。Cognition Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.01%。Cognition Therapeutics, Inc.公司简介：Cognition Therapeutics Inc 是一家临床阶段的生物制药公司，致力于发现和开发针对与年龄相关的退行性疾病和中枢神经系统和视网膜疾病的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710235507aef90125&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710235507aef90125&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CGTX","BK4007","BK4139"],"gpt_icon":0},{"id":"2450290660","title":"Cognition Therapeutics, Inc.盘中异动 早盘股价大涨5.85%报1.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450290660","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2450290660?lang=zh_cn&edition=full","pubTime":"2024-07-09 22:53","pubTimestamp":1720536819,"startTime":"0","endTime":"0","summary":"北京时间2024年07月09日22时53分，Cognition Therapeutics, Inc.股票出现波动，股价快速拉升5.85%。截至发稿，该股报1.99美元/股，成交量1.6668万股，换手率0.04%，振幅2.39%。Cognition Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.49%。Cognition Therapeutics, Inc.公司简介：Cognition Therapeutics Inc 是一家临床阶段的生物制药公司，致力于发现和开发针对与年龄相关的退行性疾病和中枢神经系统和视网膜疾病的小分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709225339941f574e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709225339941f574e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","CGTX"],"gpt_icon":0},{"id":"2449291282","title":"Cognition Therapeutics, Inc.盘中异动 临近午盘股价大涨5.60%报1.87美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449291282","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449291282?lang=zh_cn&edition=full","pubTime":"2024-07-05 23:39","pubTimestamp":1720193960,"startTime":"0","endTime":"0","summary":"北京时间2024年07月05日23时39分，Cognition Therapeutics, Inc.股票出现异动，股价快速上涨5.60%。Cognition Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.91%。Cognition Therapeutics, Inc.公司简介：Cognition Therapeutics Inc 是一家临床阶段的生物制药公司，致力于发现和开发针对与年龄相关的退行性疾病和中枢神经系统和视网膜疾病的小分子疗法。消息层面，截至23时39分，《Rodman & Renshaw：重申Cognition Therapeutics评级》资讯为影响Cognition Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705233920aef83052&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705233920aef83052&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CGTX","BK4007","BK4139","LENZ"],"gpt_icon":0},{"id":"2448104359","title":"背景资料-礼来紧随百健-艾赛之后，获得美国食品及药物管理局对阿尔茨海默氏症药物的批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2448104359","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448104359?lang=zh_cn&edition=full","pubTime":"2024-07-03 20:18","pubTimestamp":1720009106,"startTime":"0","endTime":"0","summary":"     路透7月3日 -    礼来公司  的Kisunla周二获得了美国食品和药物管理局的标准批准，用于减缓阿尔茨海默氏症的进展。Kisunla是继百健  和日本卫材  的Leqembi之后，第二种获得美国监管机构传统批准的治疗脑萎缩疾病的药物，这在一个经历了多次失败的领域是一个重要的里程碑。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CGTX","IE00B894F039.SGD","LU0708995401.HKD","LU2237443978.SGD","ANVS","LU0122379950.USD","BK4532","IE00B19Z9P08.USD","LU2264538146.SGD","BIVI","BIIB","LU1804176565.USD","IE0002141913.USD","IE00BJJMRZ35.SGD","LGVN","LU0061475181.USD","LU0882574055.USD","COYA","IE0004445239.USD","LU1057294990.SGD","ACW.AU","LU1551013342.USD","LU1988902786.USD","ACIU","BK4533","LLY","LU1023059063.AUD","LU2237443382.USD","LU2237443622.USD","LU0058720904.USD","LU2468319806.SGD","BK4534","LU2237438978.USD","IE00BJT1NW94.SGD","GB00BDT5M118.USD","LU0320765992.SGD","LU1280957306.USD","LU1551013425.SGD","LU0289739699.SGD","BK4007","LU0943347566.SGD","LU0256863811.USD","LU0079474960.USD","LU0109391861.USD","LU1814569148.SGD","LU2491050071.SGD","IE00B1BXHZ80.USD","LU2237443549.SGD","BK7067","LU2491049909.HKD"],"gpt_icon":0},{"id":"2448254167","title":"Rodman & Renshaw：重申Cognition Therapeutics(CGTX.US)评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2448254167","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448254167?lang=zh_cn&edition=full","pubTime":"2024-07-03 01:33","pubTimestamp":1719941604,"startTime":"0","endTime":"0","summary":"Rodman&Renshaw：重申cognition Therapeutics(CGTX.US)评级，由买入调整至买入评级,目标价由14.00美元调整至14.00美元。Cognition Therapeutics(CGTX.US)公司简介：Cognition Therapeutics Inc是一家临床阶段的生物制药公司，致力于发现和开发创新的小分子疗法，针对与年龄相关的退行性疾病和中枢神经系统和视网膜疾病。其主要候选产品CT1812是一种口服小分子拮抗剂，旨在穿透血脑屏障并选择性结合S2R复合物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407030145349ef61740&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407030145349ef61740&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CGTX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cogrx.com","stockEarnings":[{"period":"1week","weight":0.098},{"period":"1month","weight":-0.6758},{"period":"3month","weight":-0.6724},{"period":"6month","weight":-0.6724},{"period":"1year","weight":-0.5831},{"period":"ytd","weight":-0.653}],"compareEarnings":[{"period":"1week","weight":0.0423},{"period":"1month","weight":-0.0209},{"period":"3month","weight":0.0446},{"period":"6month","weight":0.1072},{"period":"1year","weight":0.258},{"period":"ytd","weight":0.1636}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cognition Therapeutics, Inc.于2007年8月21日根据特拉华州法律注册成立。该公司是一家临床阶段的生物制药公司，致力于发现和开发针对年龄相关退行性疾病和中枢神经系统（CNS）和视网膜疾病的创新小分子疗法。目前可用于这些疾病的疗法是有限的，许多疾病没有批准的疗法或治疗方法。他们的目标是通过最初利用他们在σ-2 (sigma-2) 受体或S2R方面的专业知识，为患有这些退行性疾病的患者开发疾病改善疗法。","exchange":"NASDAQ","name":"Cognition Therapeutics, Inc","nameEN":"Cognition Therapeutics, Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cognition Therapeutics, Inc(CGTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cognition Therapeutics, Inc(CGTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cognition Therapeutics, Inc,CGTX,Cognition Therapeutics, Inc股票,Cognition Therapeutics, Inc股票老虎,Cognition Therapeutics, Inc股票老虎国际,Cognition Therapeutics, Inc行情,Cognition Therapeutics, Inc股票行情,Cognition Therapeutics, Inc股价,Cognition Therapeutics, Inc股市,Cognition Therapeutics, Inc股票价格,Cognition Therapeutics, Inc股票交易,Cognition Therapeutics, Inc股票购买,Cognition Therapeutics, Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cognition Therapeutics, Inc(CGTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cognition Therapeutics, Inc(CGTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}